Chronically administered exogenous growth hormone at supraphysiological doses may propagate growth hormone-sensitive tumors. — Whalespan
Chronically administered exogenous growth hormone at supraphysiological doses may propagate growth hormone-sensitive tumors.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“keep in mind that growth hormone is indiscriminate with respect to which tissues it grows so if you happen have an existing tumor on a given body part or within a given body part it will encourage growth of that tumor as well that's one of the reasons some people are cautious about taking growth hormone”
Conflict Watch
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
“I think that there are probably a lot of reasons why growth hormone chronically given exogenously, especially if it's kind of super physiological, could be problematic. If for example, if you have a tumor that is growth hormone or or you know sensitive to growth hormone um and it's already initiated, are you propagating it?”